Company profile for GenKOre

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

GenKOre is a start-up spun off from the Korea Research Institute of Bioscience and Biotechnology (KRIBB), which is a government-invested research institute in Korea. It has platform business through hypercompact genome editing platform. GenKOre develops AAV/ non-AAV-based gene therapy and animals/plants using its own genome editing system. Recently, GenKOre expanded its research facility in Seoul to attract more researchers...
GenKOre is a start-up spun off from the Korea Research Institute of Bioscience and Biotechnology (KRIBB), which is a government-invested research institute in Korea. It has platform business through hypercompact genome editing platform. GenKOre develops AAV/ non-AAV-based gene therapy and animals/plants using its own genome editing system. Recently, GenKOre expanded its research facility in Seoul to attract more researchers and aim to develop a gene therapy based on hypercompact genome editing technology and to seek collaborations with pharmaceutical companies and academia.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Korea
Address
Address
Room 303, Bio Venture Center-dong, 125, Gwahak-ro, Yuseong-gu, Daejeon
Telephone
Telephone
042-710-0988
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Natural Products Expo

Natural Products Expo

Not Confirmed

envelop Contact Supplier

Natural Products Expo

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
GenKOre signs pacts worth up to $650M biobucks for gene-editing tech
GenKOre signs pacts worth up to $650M biobucks for gene-editing tech

27 Jan 2023

// Gabrielle Masson FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/2-deals-2-weeks-genkore-signs-pacts-worth-650m-biobucks-gene-editing-tech

Gabrielle Masson FIERCE BIOTECH
27 Jan 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty